天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook--->CAS DataBase List--->34783-48-7

34783-48-7

34783-48-7 Structure

34783-48-7 Structure
IdentificationBack Directory
[Name]

(3S)-3-amino-1-hydroxy-1,2,3,4-tetrahydroquinolin-2-one
[CAS]

34783-48-7
[Synonyms]

PF-04859989
PE-04859989
PF 04859989,PF04859989
(3S)-3-amino-1-hydroxy-1,2,3,4-tetrahydroquinolin-2-one
2(1H)-Quinolinone, 3-amino-3,4-dihydro-1-hydroxy-, (3S)-
[EINECS(EC#)]

808-880-5
[Molecular Formula]

C9H10N2O2
[MDL Number]

MFCD18633107
[MOL File]

34783-48-7.mol
[Molecular Weight]

178.19
Chemical PropertiesBack Directory
[Boiling point ]

361.6±52.0 °C(Predicted)
[density ]

1.387±0.06 g/cm3(Predicted)
[pka]

8.37±0.40(Predicted)
Hazard InformationBack Directory
[Enzyme inhibitor]

This systemically available KAT II inhibitor (FW = 178.19 g/mol; CAS 34783-48-7; IUPAC: (3S)-3-amino-1-hydroxy-3,4-dihydroquinolin-2(1H)- one) irreversibly inhibits kynurenine amino transferase II, or KAT II, with Ki = 23 nM, kinact/Ki 112,000 M–1 s –1 , IC50 = 263 nM, and PartitionCoefficientn-octanol/H2O = 3 x 108. This inhibitor most likely makes an enamine adduct with enzyme-bound pyridoxal-P. Rationale: Kynurenate is a tryptophan-derived endogenous antagonist for glutamate and a7-nicotinic acetylcholine receptors in the brain. Increased levels are observed postmortem in the brains of patients with a range of neurocognitive disorders, including schizophrenia. Kynurenate may well contribute to the cognitive symptoms of these conditions. Pharmacology: PF-04859989 restores glutamate release "transients" evoked by ejections of nicotine into the prefrontal cortex of rats exhibiting elevated kynurenate levels. Systemic administration of PF-04859989 30 min prior to administration of Lkynurenine (but not when administered 30 min after L-kynurenine) restores glutamatergic transients recorded up to 120 min after the administration of the KAT II inhibitor. Furthermore, the KAT-II inhibitor significantly reverses L-kynurenine-induced elevations of brain KYNA levels. The KATII inhibitor does not affect nicotine-evoked glutamatergic transients in rats not pre-treated with L-kynurenine
34783-48-7 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000 , +1-00000000000
Website: https://www.targetmol.com/
Company Name: TargetMol Chemicals Inc.
Tel: +8613564774135 , +8613564774135
Website:
Company Name: ChemCell Biomedicine Co.,Ltd.  
Tel: 020-13556033878 2965585218 13556033878
Website: http://www.approvedhomemanagement.com/ShowSupplierProductsList15061/0.htm
Company Name: ATK CHEMICAL COMPANY LIMITED  
Tel: 021-51619050 13301662590
Website: www.atkchemical.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:34783-48-7 Related Product Information